261763-36-4 Usage
Uses
Used in Pharmaceutical Industry:
2,6-Difluoro-3-methylbenzamide is used as a building block for the synthesis of various pharmaceuticals, contributing to the development of new drugs with improved therapeutic properties. Its unique structure allows for the creation of molecules with specific biological activities, making it a valuable component in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical industry, 2,6-difluoro-3-methylbenzamide serves as a key intermediate in the synthesis of pesticides and other agrochemicals. Its incorporation into these compounds can enhance their effectiveness in controlling pests and diseases, thereby improving crop yields and food security.
Used in Organic Chemistry Research:
2,6-Difluoro-3-methylbenzamide is utilized as a research compound in the field of organic chemistry, particularly for studying organic reactions and the construction of complex molecules. Its unique structure and properties make it an interesting subject for exploration, potentially leading to new insights and advancements in chemical synthesis and molecular design.
Used in the Preparation of Other Organic Compounds:
As an intermediate, 2,6-difluoro-3-methylbenzamide plays a crucial role in the synthesis of a wide range of organic compounds. Its versatility and reactivity enable the formation of various molecular structures, which can be further utilized in different applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 261763-36-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,7,6 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 261763-36:
(8*2)+(7*6)+(6*1)+(5*7)+(4*6)+(3*3)+(2*3)+(1*6)=144
144 % 10 = 4
So 261763-36-4 is a valid CAS Registry Number.
261763-36-4Relevant academic research and scientific papers
FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF
-
Paragraph 00479-00480, (2021/02/12)
The present invention provides compounds, compositions thereof, and methods of using the same. The present invention also relates to compounds and methods useful for binding and modulating the activity of cereblon (CRBN), especially for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
